AVBP

ARRIVENT BIOPHARMA INC

AVBP·04272N102·US·Common Stock·Healthcare - Biotechnology-Activist

AVBP (ARRIVENT BIOPHARMA INC) is held by 84 institutional investors as of Q1 2026. Largest holders: HHLR ADVISORS, LTD. ($90.6M), FMR LLC ($69.6M), BlackRock, Inc. ($58.4M). Net institutional sentiment: Bullish.

84
Holders
(5 Elite)
$459.9M
Total Value
71% (82)
Consensus
58 buying - 24 selling
13F: Insider & Congress:
AVBPSmart Money Verdict
View all
Held by 84 funds
5 elite
Who's Trading
ActivistFMR LLCFMR LLC6.8%May 6, 2026
ActivistSVSofinnova Venture Partners XI, L.P. ("SVP XI")4.1%Mar 5, 2026
ActivistHIHillhouse Investment Management, Ltd.9.5%Feb 17, 2026
ActivistIAINFINITUM ASSET MANAGEMENT, LLC9.9%Feb 17, 2026
ActivistThe Vanguard GroupThe Vanguard Group4.5%Jan 30, 2026
ActivistBlackRock, Inc.BlackRock, Inc.5.6%Jan 21, 2026
ActivistOAOctagon Capital Advisors LP4.9%Nov 14, 2025
ActivistHHHBM Healthcare Investments (Cayman) Ltd.5.4%Oct 15, 2025
ActivistNANovo Holdings A/S4.9%Aug 14, 2025
ActivistOAORBIMED ADVISORS LLC7.5%Aug 13, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
3.9M$90.6M5.4%+87.74%
0
Decreased
3M(-18.6%)$69.6M0.0%+44.91%
0
Increased
2.5M(+6.6%)$58.4M0.0%+33.56%
31
New
1.5M$35.3M0.0%+40.73%
40
Increased
1.4M(+30.2%)$32.8M0.0%+49.74%
36
Increased
853,427(+14.9%)$19.7M0.0%+52.48%
33
Increased
803,652(+6.7%)$18.5M0.0%+62.81%
30
Increased
748,195(+245.3%)$17.3M0.0%+46.43%
46
Increased
486,263(+7.8%)$11.2M0.0%+76.71%
30
Increased
426,281(+890.7%)$9.8M0.0%+42.66%
45
Increased
425,923(+51.1%)$9.8M0.0%+59.98%
38
Increased
368,795(+58.1%)$8.5M0.0%+53.82%
39
Increased
268,812(+9.4%)$6.2M0.0%+57.66%
30
Increased
258,772(+3.3%)$6M0.0%+63.94%
28
New
253,852$5.9M0.0%+40.73%
38
New
242,050$5.6M0.0%+40.73%
37
New
217,127$5M0.0%+40.73%
37
Increased
180,028(+51.9%)$4.2M0.0%+54.39%
37
Decreased
166,157(-63.8%)$3.8M0.0%+62.60%
0
Increased
147,639(+0.2%)$3.4M0.0%+75.88%
26

Showing 1-20 of 90

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used